Browsing by Subject "Erectile Dysfunction"
Now showing items 1-8 of 8
-
Adjunctive Treatment with Lodenafil Carbonate for Erectile Dysfunction in Outpatients with Schizophrenia and Spectrum: A Randomized, Double-Blind, Crossover, Placebo-Controlled Trial
(Wiley-Blackwell, 2013-04-01)Introduction. Evidence is accumulating to support the presence of erectile dysfunction in patients with schizophrenia. This dysregulation may be amenable to therapeutic intervention to improve adherence and quality of life ...
-
Angiotensin-Converting Enzyme Polymorphism and Erectile Dysfunction Complaints in the Brazilian Population
(Wiley-Blackwell, 2010-08-01)Introduction. Angiotensin-converting enzyme (ACE) is the major regulator of circulatory homeostasis. An insertion/deletion (I/D) polymorphism in the ACE gene has been associated with marked differences in serum ACE levels ...
-
Association Analysis of Endothelial Nitric Oxide Synthase G894T Gene Polymorphism and Erectile Dysfunction Complaints in a Population-Based Survey
(Wiley-Blackwell, 2010-03-01)Introduction.Erectile dysfunction (ED) is a common disorder leading to a serious, negative impact on the quality of the patient's life. the gene encoding endothelial nitric oxide synthase (eNOS) is an interesting candidate ...
-
The Effectiveness of Psychological Interventions for the Treatment of Erectile Dysfunction: Systematic Review and Meta-Analysis, Including Comparisons to Sildenafil Treatment, Intracavernosal Injection, and Vacuum Devices
(Blackwell Publishing, 2008-11-01)In contrast to the impressive advances in somatic research of erectile dysfunction (ED), scientific literature shows contradictory reports on the results of psychotherapy for the treatment of ED.Authors conducted a ...
-
Efficacy and Tolerability of Lodenafil Carbonate for Oral Therapy in Erectile Dysfunction: A Phase II Clinical Trial
(Wiley-Blackwell, 2009-02-01)Oral treatment with phosphodiesterase type 5 inhibitor (PDE5) is considered the first-line treatment for patients with erectile dysfunction (ED). Lodenafil carbonate (LC) is a novel PDE5.This is a phase II, prospective, ...
-
Genetics of Erectile Dysfunction: A Review of the Interface between Sex and Molecular Biomarkers
(Wiley-Blackwell, 2011-11-01)Introduction. in recent years, new tools for the study of molecular biology and genetics have resulted in significant contributions to the scientific community. the potential use of genetic variations as biomarkers in the ...
-
Impairment of Sexual Function in Rats with Epilepsy
(Wiley-Blackwell, 2012-09-01)Introduction. Epilepsy is a chronic disease that affects men and women of all ages, with different levels of severity. Many individuals with epilepsy also suffer from impairments in sexual function. However, it is difficult ...
-
PDEI-5 for Erectile Dysfunction: A Potential Role in Seizure Susceptibility
(Wiley-Blackwell, 2012-08-01)Introduction. There is a high prevalence of erectile dysfunction (ED) in men with epilepsy; however, few studies have been conducted concerning the treatment of ED in this neurological group. Aim. the main purpose of this ...
